# 1st Gen Model McKesson Corporation Drugs, proprietaries, & sundries

Subscribe >> Deal exit on
Oct. 24, 2017
Deal entry on
Oct. 24, 2017
0.95%Expected margin
68.49% successful of 73 deals
$148.30 Last close price
at 23-oct-2017

MCK

Model's trade recommendations 0.06% Return for period

-5.98% Annual return

$31.70B Market Cap

β 1.17  

MCK

Model (following trade recommendations)

MCK

Underlying stock

S&P 500

Index
Return for period 0.06%
-4.25%
1.78%
52wk return 17.08%
-7.47%
16.82%
52wk Range
124.11—168.12
2000.54—2399.63
Sortino ratio -0.37
Sharpe ratio -0.32
Norm. RMSE 0.28%
Downside risk 13.78%
Volatility 16.16%
  • 1.36 (0.90%) Div (Yield)
  • BUY Analysts consensus recommendation

McKesson Corporation, the world's largest health care service and technology company, delivers unique supply and information management solutions that reduce costs and improve quality for its health care customers. The Company is organized under two operating segments: Health Care Supply Management and Health Care Information Technology.

Industry sector: Medical

Sector classification: Drugs, proprietaries, & sundries

Deep Learning based analysis and prediction model for McKesson Corporation (MCK) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for MCK model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 208M
P/E 12.76
Shares Outstanding 210M
% Held by Insiders 1.20%
% Held by Institutions 85.29%
EPS (last reported FY) $11.61
EPS (last reported Q) $2.46
EPS, estimated (last reported Q) $2.81
Total revenues $199 B
Net income $5 B